Výsledky vyhledávání

Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPD

Publikováno v: Chest. 112:1514-1521

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b7e2007b101ba1192cf690865be616b
https://doi.org/10.1378/chest.112.6.1514

Zobrazit plný text záznamu

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

Autor: A Wanner, S S Menjoge, Richard ZuWallack, T Witek, Richard Casaburi, C W Serby, Paul W. Jones, Pedro G San, D A Mahler

Publikováno v: The European respiratory journal. 19(2)

Currently available inhaled bronchodilators used as therapy for chronic obstructive pulmonary disease (COPD) necessitate multiple daily dosing. The present study evaluates the long-term safety and efficacy of tiotropium, a new once-daily anticholiner

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d216052eb6a1ea7222cfe0d46677d73a
https://pubmed.ncbi.nlm.nih.gov/11865999

Zobrazit plný text záznamu

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group

Autor: R, Casaburi, D D, Briggs, J F, Donohue, C W, Serby, S S, Menjoge, T J, Witek

Publikováno v: Chest. 118(5)

To compare the bronchodilator efficacy and safety of tiotropium and placebo.A 3-month, randomized, double-blind, placebo-controlled, multicenter trial.Outpatient.Four hundred seventy patients with stable COPD (mean FEV(1) = 38.6% predicted).Tiotropiu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6251927b55da8b1a090112c56b64ac9c
https://pubmed.ncbi.nlm.nih.gov/11083677

Zobrazit plný text záznamu

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials

Autor: S I, Rennard, C W, Serby, M, Ghafouri, P A, Johnson, M, Friedman

Publikováno v: Chest. 110(1)

Bronchodilators are routinely used in the long-term therapy of patients with COPD. These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term and short-term benefits, however, are not necessarily equivalent. We evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6f5bfba15c604c90bacbe74d875ad75e
https://pubmed.ncbi.nlm.nih.gov/8681663

Zobrazit plný text záznamu

Fenoterol in exercise-induced asthma. Effect of dose on efficacy and duration of action

Autor: P, König, N L, Hordvik, C W, Serby

Publikováno v: Chest. 85(4)

The effectiveness of inhaled fenoterol doses of 0.4 mg and 0.8 mg in preventing exercise-induced asthma was investigated in 12 patients. Exercise-induced asthma was prevented by both doses for two hours after administration, but the effect of neither

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1852b9937096307335e6af88dd1a67ee
https://pubmed.ncbi.nlm.nih.gov/6368141

Zobrazit plný text záznamu

Comparison of oral and inhaled metaproterenol for prevention of exercise-induced asthma

Autor: C. W. Serby, P. A. Eggleston, P. König

Publikováno v: Clinical allergy. 11(6)

The effectiveness of inhaled versus oral metaproterenol in preventing exercise-induced asthma (EIA) was studied. Inhaled metaproterenol given 10 min before the exercise significantly reduced the degree of EIA in a group of twenty-four patients, and i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7408556a71a932a992611ebbdcc5806c
https://pubmed.ncbi.nlm.nih.gov/7333003

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání